Market Place
Sourcing Support
New Positive Data From Brensocatib Study To Be Presented At Conference
03 Jul 2024 //
PR NEWSWIRE
Insmed shares double as lung drug data convince Wall Street
29 May 2024 //
BIOPHRAMADIVE
Insmed: Positive Topline ASPEN Data For Brensocatib In Bronchiectasis
28 May 2024 //
PR NEWSWIRE
Insmed Completes Enrollment of Patients in Phase 3 ASPEN Study of Brensocatib
31 Mar 2023 //
PR NEWSWIRE
Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients
02 Dec 2020 //
PRNEWSWIRE
Phase 2 WILLOW Study of Brensocatib in Patients shows positive results
07 Sep 2020 //
PRNEWSWIRE
Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients
25 Jun 2020 //
PRNEWSWIRE
Positive Results from Ph2 WILLOW Study of Brensocatib Non-Cystic Fibrosis
24 Jun 2020 //
PRNEWSWIRE
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib i
08 Jun 2020 //
PRNEWSWIRE
Insmed to Showcase New Brensocatib Data at American Thoracic Society Trials
20 May 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.